Beijing, China

Maeng Sup Kim

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Beijing Hanmi Pharmaceutical Co., Ltd., Innovent Biologics (Suzhou) Co., Ltd.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maeng Sup Kim. Retrieved from https://idiyas.com/inventor/maeng-sup-kim-yvji025p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maeng Sup Kim: Innovator in Bispecific Antibody Development

Introduction

Maeng Sup Kim is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. His innovative work has the potential to impact the treatment of complex diseases.

Latest Patents

One of Maeng Sup Kim's notable patents is titled "Anti-PD-1/anti-HER2 natural antibody structural heterodimeric bispecific antibody and method of preparing same." This patent describes a highly stable heterodimeric bispecific antibody that possesses natural IgG characteristics without any mismatch between the heavy chain and light chain. The bispecific antibody is designed to bind to two target molecules simultaneously, showcasing excellent effects in the treatment of complex diseases.

Career Highlights

Throughout his career, Maeng Sup Kim has worked with leading pharmaceutical companies, including Beijing Hanmi Pharmaceutical Co., Ltd. and Innovent Biologics (Suzhou) Co., Ltd. His experience in these organizations has allowed him to refine his expertise in antibody development and therapeutic applications.

Collaborations

Maeng Sup Kim has collaborated with notable professionals in the field, including Yaping Yang and Nanmeng Song. These collaborations have further enhanced his research and development efforts in bispecific antibodies.

Conclusion

Maeng Sup Kim's innovative work in bispecific antibody development positions him as a key figure in biotechnology. His contributions have the potential to advance therapeutic strategies for complex diseases, making a significant impact in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…